Who is sponsoring NCT06924567?

NCT06924567 is sponsored by Georgios Tsikandylakis, MD PhD.

What drugs are being tested in NCT06924567?

Interventions in NCT06924567: Implant motion provocation CT.

What condition does NCT06924567 study?

NCT06924567 studies Loosening, Prosthesis, Hip Arthropathy.

Is NCT06924567 still recruiting?

NCT06924567 is currently not yet recruiting. Last updated 12 March 2026.

Last reviewed 2026-03-12 · How we verify

NCT06924567: MULTICIMA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radiographic Stability of Hip Prosthesis Prior to Revision Surgery

Not yet recruiting Last updated 12 March 2026

What this trial tests

trial testing Implant motion provocation CT in Loosening, Prosthesis in 600 participants. Not yet recruiting.

Timeline

15 September 2026

Primary endpoint
31 December 2029

31 December 2029

Quick facts

Lead sponsor	Georgios Tsikandylakis, MD PhD
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	600
Start date	15 September 2026
Primary completion	31 December 2029
Estimated completion	31 December 2029
Sites	6 locations across Denmark, Sweden, Norway

Drugs / interventions tested

Implant motion provocation CT

Conditions studied

Loosening, Prosthesis — all drugs for Loosening, Prosthesis →
Hip Arthropathy — all drugs for Hip Arthropathy →

Sponsor

Georgios Tsikandylakis, MD PhD

Who can join

Eligibility, any sex, with Loosening, Prosthesis or Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this validation study is to compare the preoperative implant stability, assessed by Implant Movement Analysis (IMA), provocation dual CT scans, with the intraoperative stability evaluation in revision hip arthoplasty. The main question it aims to answer is: Does IMA reflect the intraoperative clinical evaluation of implant stability? Participants scheduled for revision hip arthoplasty will undergo IMA preoperativelly in addition to rutine clinical work up. During revision arthoplasty, a surgeon blinded to the IMA results will assess clinically the stability of the hip prosthesis. IMA will be compared with the intraoperative findings to assess IMAs sensitivity and specificity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06924567 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Georgios Tsikandylakis, MD PhD
Last refreshed: 12 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06924567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing